BioLine RX Ltd - ADR (BLRX) Price & News - Google Finance (2024)

Dow Jones38,571.03-0.30%-115.29Dow Jones38,571.030.30%
Nasdaq16,828.67+0.56%+93.65Nasdaq16,828.670.56%
Russell2,059.68-0.50%-10.44Russell2,059.680.50%
VIX13.11+1.47%+0.19VIX13.111.47%

HomeBLRX • NASDAQ

BioLine RX Ltd - ADR

$0.73

Jun 3, 8:15:00 PM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Tonix Pharmaceuticals Holding Corp

$0.16

TNXP0.55%

Ardelyx Inc

$6.92

ARDX0.87%

Vaxart Inc

$0.83

VXRT1.60%

Alarum Technologies Ltd - ADR

$36.47

ALAR2.50%

Kezar Life Sciences Inc

$0.71

KZR2.12%

Oncolytics Biotech Inc

$1.07

ONCY0.00%

Ocuphire Pharma Inc

$1.68

OCUP0.00%

Enlivex Therapeutics Ltd

$1.47

ENLV8.09%

Geron Corp

$3.83

GERN7.89%

Affimed NV

$7.33

AFMD68.51%

In the news

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/28/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

6.86M

Operating expense

Represents the total incurred expenses through normal operations

10.22M15.42%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-696.00K94.28%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-10.15

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-3.92M54.34%

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/28/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

28.17M-34.92%

Total assets

The total amount of assets owned by a company

51.60M-24.83%

Total liabilities

Sum of the combined debts a company owes

38.54M30.50%

Total equity

The value of subtracting the total liabilities from the total assets of a company

13.06M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

1.09B

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

74.56

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-20.87%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-49.02%

Net change in cash

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/28/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-696.00K94.28%

Cash from operations

Net cash used or generated for core business activities

-14.11M-76.01%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

16.69M151.23%

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

-894.00K-1,724.49%

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

1.74M214.07%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-13.50M-155.85%

US listed security

Listed on NASDAQ

Previous close

The last closing price

$0.75

Day range

The range between the high and low prices over the past day

$0.73 - $0.77

Year range

The range between the high and low prices over the past 52 weeks

$0.55 - $2.53

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

57.19M USD

Avg Volume

The average number of shares traded each day over the past 30 days

371.48K

About

BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia

CEO

Philip A. Serlin

Founded

2003

Employees

79

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average38,571.030.30%
TSLATesla Inc$176.291.01%
AAPLApple Inc$194.030.93%
AMZNAmazon.com Inc$178.341.08%
BABAAlibaba Group Holding Ltd - ADR$77.900.56%
MSFTMicrosoft Corp$413.520.39%
FFord Motor Co$12.190.49%
IndexVIX13.111.47%
IndexNasdaq Composite16,828.670.56%
NXSTNexstar Media Group Inc$163.091.57%
BABoeing Co$184.573.92%
DISWalt Disney Co$102.771.10%
NFLXNetflix Inc$633.791.22%
NVDANVIDIA Corp$1,150.004.90%
UALUnited Airlines Holdings Inc$52.720.51%
PFEPfizer Inc$29.312.27%

People also search for

TNXPTonix Pharmaceuticals Holding Corp$0.160.55%
ARDXArdelyx Inc$6.920.87%
VXRTVaxart Inc$0.831.60%
ALARAlarum Technologies Ltd - ADR$36.472.50%
KZRKezar Life Sciences Inc$0.712.12%
ONCYOncolytics Biotech Inc$1.070.00%
OCUPOcuphire Pharma Inc$1.680.00%
ENLVEnlivex Therapeutics Ltd$1.478.09%
GERNGeron Corp$3.837.89%
AFMDAffimed NV$7.3368.51%
BCLIBrainstorm Cell Therapeutics Inc$0.502.75%
CRVSCorvus Pharmaceuticals Inc$2.212.31%
BCRXBioCryst Pharmaceuticals Inc$6.795.11%
ATOSAtossa Therapeutics Inc$1.321.54%
CUECue Biopharma Inc$1.651.23%
AXSMAxsome Therapeutics Inc$74.741.78%
ALLTAllot Ltd$2.140.00%
SANASana Biotechnology Inc$7.814.13%

BioLine RX Ltd - ADR (BLRX) Price & News - Google Finance (2)HelpSend feedbackPrivacyTermsDisclaimer

BioLine RX Ltd - ADR (BLRX) Price & News - Google Finance (2024)

References

Top Articles
Latest Posts
Article information

Author: Carlyn Walter

Last Updated:

Views: 5812

Rating: 5 / 5 (70 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Carlyn Walter

Birthday: 1996-01-03

Address: Suite 452 40815 Denyse Extensions, Sengermouth, OR 42374

Phone: +8501809515404

Job: Manufacturing Technician

Hobby: Table tennis, Archery, Vacation, Metal detecting, Yo-yoing, Crocheting, Creative writing

Introduction: My name is Carlyn Walter, I am a lively, glamorous, healthy, clean, powerful, calm, combative person who loves writing and wants to share my knowledge and understanding with you.